Barrett’s Esophagus |
| |||
|
Biopsy with no dysplasia or cellular changes |
Us 0 | ||
|
No biopsy, mild |
T2 | ||
|
|
| ||
Bell’s Palsy/Blindness |
| |||
|
Recovered, no remaining impairment |
0 | ||
|
Slight impairment |
Us 0 | ||
|
Others |
IC | ||
|
|
| ||
Breast Nodules, Mass, Fibrocystic Breast Disease |
| |||
|
No family history of breast cancer or family history unknown |
| ||
|
|
Present, no nodules, biopsy findings (hyperplasia or dysplasia) of concern, good follow-up, benign |
| |
|
|
|
Pathology |
Us 0 |
|
|
Undefined prominent nodules of concern |
PP | |
|
|
Fibrocystic disease, no nodules or biopsy findings (hyperplasia or dysplasia) of concern, good follow-up |
Us 0 | |
|
|
Undefined prominent nodules of concern |
Decline | |
|
|
Biopsy demonstrating hyperplasia or dysplasia |
T4 to Decline | |
|
|
|
|
Bronchiectasis |
| |||
|
Present |
| ||
|
|
Unilateral |
| |
|
|
|
Minimal symptoms, no chronic lung disease present |
|
|
|
|
Less than 10% underweight |
T2-Decline |
|
|
|
Underweight 10% or more |
T3-Decline |
|
|
|
Others, including emphysema, asthma or COPD |
Decline |
|
|
Bilateral |
Decline | |
|
In history |
| ||
|
|
Bilateral involvement, operated |
Decline | |
|
|
Unilateral involvement, operated, no residual effects |
| |
|
|
|
Segmental resection |
|
|
|
|
0-6 mo |
PP |
|
|
|
6 mo-2 yr |
T2-Decline |
|
|
|
Over 2 yr |
T2 |
|
|
|
Lobectomy |
|
|
|
|
0-2 yr |
0-T3 |
|
|
|
2 yr and up |
Us 0 |
|
|
|
Pneumonectomy |
|
|
|
|
0-2 yr |
0-T3 |
|
|
With remaining impairments |
IC-Decline | |
|
|
Smoking or exposure to dust, occupational or environmental respiratory hazards |
Decline | |
|
|
|
| |
Bronchitis |
| |||
|
Acute |
| ||
|
|
Present |
Us 0 | |
|
|
In history |
| |
|
|
|
Occasional isolated episodes |
Us 0 |
|
|
|
Recurrent episodes |
See Chronic Bronchitis below |
|
|
|
Others, including emphysema, asthma or COPD |
Decline |
|
| |||
|
|
Mild |
| |
|
|
|
Non-smoker |
|
|
|
|
No complications |
0-T2 |
|
|
|
With complications |
IC |
|
|
|
Still smoking |
T4 minimum |
|
|
Moderate, not on steroid therapy |
| |
|
|
|
Non-smoker |
|
|
|
|
No complications |
T3-Decline |
|
|
|
With complications |
IC |
|
|
|
Still smoking |
T6 to Decline, Us Decline |
|
|
Severe, all cases |
Decline | |
|
|
With exposure to dust, toxic air or other irritants |
Decline | |
|
|
|
|
|
Buerger’s Disease (Thromboangiitis Obliterans) – An idiopathic vasculitis affecting small and medium-sized blood vessels of the extremities with frequent occlusion of the vascular lumen | ||||
|
Still smoking or diabetes mellitus or coronary heart disease |
Decline | ||
|
Stopped smoking and no symptoms or complications |
| ||
|
|
0-5 yr |
Decline | |
|
|
5-10 yr |
T2 to Decline | |
|
|
Over 10 yr |
Us 0 | |
|
Stopped smoking but symptoms persist and/or hypertension present |
Decline | ||
|
|
|
|
|
Build – Please contact our New Business Contact Center at (800) 869-0355, Ext. 4264. | ||||
|
|
|
|
|
Bundle Branch Blocks – See Electrocardiogram | ||||
|
|
|
|
|
Bypass (Gastric), Gastroplasty, Gastric Stapling, Lap band surgery, Other weight loss surgery | ||||
|
|
0-6 mo |
PP | |
|
|
6 mo-1 yr |
Build rate + T2 | |
|
|
1-2 yr normal build, stable |
T2 | |
|
|
2 yr and up, normal build, all else normal |
Us 0 |